Mar 18 |
Longevity Acquisition Corporation Announces Results of Special Meeting of Shareholders
|
Feb 27 |
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Longevity Acquisition Corp. - LOAC
|
Feb 8 |
Longevity Acquisition Corporation Announces 4D pharma Clinical Trial Collaboration and Supply Agreement for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
|
Feb 3 |
Longevity Acquisition Corporation Announces 4D pharma Update on Oncology Program
|
Jan 7 |
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SNSS, LOAC, FBSS, and CPAH Mergers
|
Dec 21 |
Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers Initiative
|
Dec 17 |
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of ELY, LOAC, ROCH, and NGA Mergers
|
Dec 11 |
Longevity Acquisition Corporation Regains Compliance with Nasdaq Listing Requirement
|
Nov 17 |
Longevity Acquisition Corporation Announces Increased Cash Contribution for the Extension
|
Nov 16 |
SHAREHOLDER ALERT: WeissLaw LLP Reminds LOAC, SMMCU, CCR, and CBMG Shareholders About Its Ongoing Investigations
|
Nov 7 |
SHAREHOLDER ALERT: WeissLaw LLP Reminds DMYD, XLNX, HLIX, and LOAC Shareholders About Its Ongoing Investigations
|
Oct 27 |
SHAREHOLDER ALERT: WeissLaw LLP Investigates Longevity Acquisition Corporation
|
Oct 22 |
Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement
|